Cite

HARVARD Citation

    Lamas, M. et al. (2011). Use of a comprehensive panel of biomarkers to predict response to a fluorouracil––oxaliplatin regimen in patients with metastatic colorectal cancer. Pharmacogenomics. pp. 433-442. [Online]. 
  
Back to record